{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:25Z","timestamp":1755216745468,"version":"3.43.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>Fat embolism syndrome after bone marrow necrosis is an extremely rare complication in sickle cell disease associated with significant morbidity and mortality. A high index of suspicion is required for diagnosis. This case report will assist pediatric clinicians and hematologists to recognize this severe complication in patients with sickle cell disease and to promptly initiate treatment. Red flags include severe bone pain, respiratory distress, neurological impairment, decreasing platelet count, peripheral leukocyte left shift, elevated nucleated red blood cells, and significant elevation in plasma ferritin and lactate dehydrogenase. We report a pediatric patient who was diagnosed early, received urgent red cell exchange transfusion and plasma exchange, and ultimately survived this devastating complication.<\/jats:p>","DOI":"10.1097\/mph.0000000000002399","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T21:06:24Z","timestamp":1643231184000},"page":"e884-e887","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Identifying and Treating Severe Bone Marrow Necrosis and Fat Embolism Syndrome in Pediatric Patients With Sickle Cell Disease: A Case Report"],"prefix":"10.1097","volume":"44","author":[{"given":"Alessandra","family":"Bosch","sequence":"first","affiliation":[{"name":"Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salmas","family":"Watad","sequence":"additional","affiliation":[{"name":"Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Willmott","sequence":"additional","affiliation":[{"name":"Pediatrics, The Hospital for Sick Children, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole K.","family":"McKinnon","sequence":"additional","affiliation":[{"name":"Critical Care Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Malcolmson","sequence":"additional","affiliation":[{"name":"Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Kirby","sequence":"additional","affiliation":[{"name":"Hematology and Oncology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250804","first-page":"305","article-title":"Sickle cell disease","volume":"377","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ccr3.727","article-title":"Successful outcome of three patients with sickle-cell disease and fat embolism syndrome treated with intensive exchange transfusion","volume":"5","author":"Greaves","year":"2017","journal-title":"Clin Case Rep"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.3390\/jcm9113601","article-title":"Fat embolism syndrome in sickle cell disease","volume":"9","author":"Tsitsikas","year":"2020","journal-title":"J Clin Med"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1111\/bjh.15941","article-title":"Revisiting fat embolism in sickle syndromes: diagnostic and emergency therapeutic measures","volume":"186","author":"Tsitsikas","year":"2019","journal-title":"Br J Haematol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000441-200011000-00009","article-title":"Bone marrow necrosis in sickle cell disease: a description of three cases and a review of the literature","volume":"320","author":"Ataga","year":"2000","journal-title":"Am J Med Sci"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"E64","DOI":"10.1002\/ajh.25363","article-title":"Fat embolism syndrome due to bone marrow necrosis in patients with hemoglobinopathies: a life-threatening complication mimicking thrombotic thrombocytopenic purpura","volume":"94","author":"Gangaraju","year":"2019","journal-title":"Am J Hematol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ajh.10114","article-title":"Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature","volume":"70","author":"Paydas","year":"2002","journal-title":"Am J Hematol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1182\/blood.V83.11.3107.3107","article-title":"Pulmonary fat embolism: a distinct cause of severe acute chest syndrome in sickle cell anemia","volume":"83","author":"Vichinsky","year":"1994","journal-title":"Blood"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.blre.2013.12.002","article-title":"Bone marrow necrosis and fat embolism syndrome in sickle cell disease: increased susceptibility of patients with non-SS genotypes and a possible association with human parvovirus B19 infection","volume":"28","author":"Tsitsikas","year":"2014","journal-title":"Blood Rev"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s13054-015-1112-5","article-title":"Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports","volume":"19","author":"Kraj\u010dov\u00e1","year":"2015","journal-title":"Crit Care"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.5858\/arpa.2017-0251-RS","article-title":"Hyperhemolysis syndrome in patients with sickle cell disease","volume":"142","author":"Banks","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice\u2014evidence-based approach from the writing committee of the american society for apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J Clin Apher"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:04:26Z","timestamp":1754337866000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002399","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"2021-08-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}